Semaglutide has been shown to result in the highest total body weight loss percentage of around 14.9%, within FDA-approved anti-obesity medications
It involves a personalized plan that can include dietary adjustments, an exercise regimen, behavioral modifications, and, when necessary, prescribed medications like GLP-1
Additionally, recent clinical evidence has demonstrated that newly diagnosed hypothyroid individuals exhibit elevated malondialdehyde (MDA) and decreased total antioxidant capacity, supporting the link between impaired antioxidant status and heightened oxidative stress (Sultana et al
While the name skinny shots might sound catchy, the reality is that GLP-1 injections can offer more than just weight loss
Since both medications are weekly injections with similar half-lives of approximately five to seven days, the standard approach is to start semaglutide about one week after your last tirzepatide dose aligning with your normal injection day